We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.08B
AUM Growth
+$1.46B
Cap. Flow
+$1.39B
Cap. Flow %
27.41%
Top 10 Hldgs %
16.41%
Holding
2,064
New
586
Increased
519
Reduced
386
Closed
568

Sector Composition

Rank Sector Weight
1 Technology 13.8%
2 Industrials 11.19%
3 Consumer Discretionary 10.32%
4 Healthcare 10.26%
5 Financials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOG icon
1451
Northern Oil and Gas
NOG
$2.3B
$58K ﹤0.01%
4,175
+681
+19% +$13.2K
ACTG icon
1452
Acacia Research
ACTG
$450M
$57K ﹤0.01%
13,900
-14,431
-51% -$67.2K
DRD
1453
DRDGold
DRD
$1.82B
$57K ﹤0.01%
+17,984
New +$67.7K
ECYT
1454
DELISTED
Endocyte, Inc. Common Stock
ECYT
$57K ﹤0.01%
+37,811
New +$81.2K
EGLT
1455
DELISTED
Egalet Corporation
EGLT
$55K ﹤0.01%
+23,105
New +$73.8K
BTG icon
1456
B2Gold
BTG
$5.16B
$54K ﹤0.01%
19,225
-348,899
-95% -$920K
GLBL
1457
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$53K ﹤0.01%
+10,500
New +$50.8K
KA
1458
DELISTED
Kineta, Inc. Common Stock
KA
$51K ﹤0.01%
78
-41
-34% -$29.2K
ARWR icon
1459
Arrowhead Research
ARWR
$12.1B
$49K ﹤0.01%
+30,398
New +$49.2K
WKHS icon
1460
Workhorse Group
WKHS
$29.5M
$49K ﹤0.01%
+4
New +$37.5K
LPTH icon
1461
Lightpath Technologies
LPTH
$680M
$46K ﹤0.01%
+17,200
New +$48.3K
MACK
1462
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$45K ﹤0.01%
+4,646
New +$94.9K
RGLS
1463
DELISTED
Regulus Therapeutics
RGLS
$44K ﹤0.01%
+370
New +$61.8K
WCST
1464
DELISTED
Wecast Network, Inc. Common Stock
WCST
$44K ﹤0.01%
+25,034
New +$64.5K
SID icon
1465
Companhia Siderúrgica Nacional
SID
$1.43B
$43K ﹤0.01%
20,147
-1,422
-7% -$3.17K
LRMR icon
1466
Larimar Therapeutics
LRMR
$416M
$42K ﹤0.01%
+997
New +$51K
TOVX icon
1467
Theriva Biologics
TOVX
$10.2M
$40K ﹤0.01%
8
+7
+700% +$34.9K
ASXC
1468
DELISTED
Asensus Surgical, Inc.
ASXC
$39K ﹤0.01%
+4,222
New +$40.2K
KONA
1469
DELISTED
Kona Grill, Inc.
KONA
$37K ﹤0.01%
+10,027
New +$46K
WAC
1470
DELISTED
Walter Investment Mgt Corp
WAC
$37K ﹤0.01%
+39,503
New +$45.5K
LTS
1471
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$36K ﹤0.01%
+14,905
New +$36.1K
CYTR
1472
DELISTED
CytRx Corp
CYTR
$33K ﹤0.01%
+8,839
New +$30.2K
NIHD
1473
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$33K ﹤0.01%
+40,434
New +$30.9K
APVO icon
1474
Aptevo Therapeutics
APVO
$5.47M
0
DRRX
1475
DELISTED
DURECT Corp
DRRX
$32K ﹤0.01%
2,050
-149
-7% -$1.7K

Similar funds

Squarepoint's Q2 2017 Portfolio in Review

As of Q2 2017, Squarepoint held 2,064 positions worth $5.08B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Squarepoint deployed $1.39B of net new capital in Q2 2017, opening 586 new positions and adding to 519 existing holdings. Its largest new stake was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $33M trimmed.

  • Squarepoint's largest Q2 2017 buy was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
  • Squarepoint added most to VanEck Gold Miners ETF in Q2 2017, an estimated $71.9M increase.
  • Squarepoint's biggest Q2 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $33M.
  • Squarepoint fully exited iShares MSCI EAFE ETF in Q2 2017, selling an estimated $26.5M.
  • Squarepoint's ten largest holdings make up 16% of its $5.08B portfolio in Q2 2017.
  • Squarepoint opened 586 new positions and closed 568 in Q2 2017.
  • Squarepoint's portfolio value rose 40% quarter-over-quarter to $5.08B.

Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.